Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapy

AIDS Research and Human Retroviruses

Volumn 17, Issue 17, 2001, Pages 1599-1604

  Riva, Elisabetta ^a   Pistello, Mauro ^b   Narciso, Pasquale ^c   D’Offizi, Gianpiero ^c   Isola, Patrizia ^b   Galati, Vincenzo ^c   Turriziani, Ombretta ^d   Tozzi, Valerio ^c   Vincenzi, Laura ^c   Dianzani, Ferdinando ^a   Antonelli, Guido ^d  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DNA; INDINAVIR; LAMIVUDINE PLUS ZIDOVUDINE; RNA; STAVUDINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CLEARANCE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MONONUCLEAR CELL; PLASMA; PRIORITY JOURNAL; SEXUALITY; VIREMIA; VIRUS LOAD; VIRUS REPLICATION; VIRUS RESISTANCE;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DNA, VIRAL; DRUG RESISTANCE, VIRAL; FEMALE; GENES, POL; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MUTATION; PROVIRUSES; RNA, VIRAL; VIRAL LOAD;

EID: 0035695104     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922201753342004     Document Type: Article

References (22)

1. Primary HIV infection: Host responses and intervention strategies
2. Predictors of rapid progression to AIDS in HIV-1 seroconverters
3. Clinical course of primary HIV infection: Consequences for subsequent course of infection
4. Severity and prognosis of acute immunodeficiency virus type 1 illness: A dose-response relationship
5. Time of initiation of antiretroviral therapy: Impact on HIV-1 viraemia. The Swiss HIV Cohort study
6. Early establishment of a pool of latently infected, resting CD4(+) T cell during primary HIV-1 infection
7. Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection
8. TT virus levels in plasma of infected individuals with different hepatic and extrahepatic pathologies
9. Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy
10. The HIV type 1 protease inhibitor saquinavir can select for multiple mutation that confer increasing resistance
11. Effect of combination of zidovudine, didanosine, and lamivudine on primary human immunodeficiency virus type 1 infection
12. Quantification of HIV-1 viral load in lymphoid and blood cells: Assessment during four-drug combination therapy
13. Significant reduction of plasma viral load but not of proviral infected cells during suboptimal antiretroviral therapy
14. The number of HIV DNA infected mononuclear cells is reduced under HAART plus recombinant IL-2
15. Long-term evaluation of triple nucleoside therapy administered from primary HIV-1 infection
16. Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: Partial normalization of T lymphocytes subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia
17. Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infection
18. Cell-associated HIV-1 DNA quantification after highly active antiretroviral therapy-treated primary infection in patients with persistently undetectable plasma HIV-1 RNA
19. Viral load burden modification following early antiretroviral therapy of primary HIV-1 infection
20. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy
21. The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses
22. Latent reservoir and residual HIV-1 replication on antiretroviral therapy